Friday, May 30, 2008

Dong Guai

Dong guai or Chinese angelica root (or "Female Ginseng," as it is sometimes called) is an age-old, natural way to support a woman's health and reproductive system. It has been used to relieve the discomforts of PMS (pre-menstrual syndrome), dysmenorrhea (painful menstruation), amenorrhea (absence of menstruation), menorrhagia (abnormal menstruation), and may help in cases of infertility. It can re-establish and regulate the menstrual cycles in women after giving birth or when ending the use of birth control pills.

Chemical constituents of Dong Quai include coumarins, essential oils, vitamins B-1, B-2, B-5 and vitamin C, beta-carotene, acids, calcium, iron, magnesium, manganese, zinc, phosphorus, potassium, selenium, flavonoids and phytoestrogens.

Chinese Angelica Root is said to possess significant blood pressure-lowering action, due to its ability to dilate blood vessels, and it is also reported to possess calcium channel blockers, which help a wide variety of cardiovascular conditions, including hypertension, arteriosclerosis and angina. By inhibiting platelet aggregation, Chinese Angelica Root increases blood flow to the heart, brain and extremities, thereby helping to guard against stroke and heart attack. This improved circulation may also relieve tinnitus, blurred vision, palpitations and migraine headaches. Studies claim that it acts as a tranquilizer and will calm the nerves. It is also said to have pain relieving effects, and its analgesic activity, combined with its smooth-muscle relaxing properties, support its historical use in easing the discomforts in conditions such as trauma, arthritis, abdominal pain, cramps and headaches.


Chinese Angelica Root should not be used by pregnant or lactating women nor by women with a typically heavy menstrual flow. It is not recommended for diabetics, those who are taking anti-coagulants (Coumadin, aspirin, etc.) or people who are using medication for high blood pressure. Chinese Angelica Root may increase photosensitivity in sunlight.

No comments: